Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice ; volume:22 ; number:1 ; day:29 ; month:3 ; year:2022 ; pages:1-2 ; date:12.2022
BMC pulmonary medicine ; 22, Heft 1 (29.3.2022), 1-2, 12.2022
- Creator
-
Udalov, Sergey
Dumitrascu, Rio
Pullamsetti, Soni Savai
Al-tamari, Hamza M.
Weissmann, Norbert
Ghofrani, Hossein Ardeschir
Guenther, Andreas
Voswinckel, Robert
Seeger, Werner
Grimminger, Friedrich
Schermuly, Ralph T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-022-01876-5
- URN
-
urn:nbn:de:101:1-2022061810342713899574
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Udalov, Sergey
- Dumitrascu, Rio
- Pullamsetti, Soni Savai
- Al-tamari, Hamza M.
- Weissmann, Norbert
- Ghofrani, Hossein Ardeschir
- Guenther, Andreas
- Voswinckel, Robert
- Seeger, Werner
- Grimminger, Friedrich
- Schermuly, Ralph T.
- SpringerLink (Online service)
Other Objects (12)
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
2. Forschungswerkstatt Pulmonale Hypertonie
Pulmonale Hypertonie : Pathophysiologie, allgemeine Maßnahmen und Entwicklung einer pulmonal selektiven Therapie
Pulmonary hypertension : pathophysiology, diagnosis, treatment, and development of a pulmonary selective therapy
3. Forschungswerkstatt Pulmonale Hypertonie : 31.5. - 1.6.2013, Köln
Forschungswerkstatt Pulmonale Hypertonie
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
A critical role of AREG for bleomycin-induced skin fibrosis
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
2. Forschungswerkstatt Pulmonale Hypertonie
Pulmonale Hypertonie : Pathophysiologie, allgemeine Maßnahmen und Entwicklung einer pulmonal selektiven Therapie
Pulmonary hypertension : pathophysiology, diagnosis, treatment, and development of a pulmonary selective therapy
3. Forschungswerkstatt Pulmonale Hypertonie : 31.5. - 1.6.2013, Köln
Forschungswerkstatt Pulmonale Hypertonie
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
A critical role of AREG for bleomycin-induced skin fibrosis
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
2. Forschungswerkstatt Pulmonale Hypertonie
Pulmonale Hypertonie : Pathophysiologie, allgemeine Maßnahmen und Entwicklung einer pulmonal selektiven Therapie
Pulmonary hypertension : pathophysiology, diagnosis, treatment, and development of a pulmonary selective therapy
3. Forschungswerkstatt Pulmonale Hypertonie : 31.5. - 1.6.2013, Köln
Forschungswerkstatt Pulmonale Hypertonie
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
A critical role of AREG for bleomycin-induced skin fibrosis